These results, along with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the principle of focusing on ACKR3 as a novel method to modulate the opioid program, which could open new therapeutic avenues for opioid-related Ailments. Disclaimer: The above is a https://snoopg481wsm9.wikijm.com/user